-transparent.png){kind=logo}
L-754,394 is a potent and specific inhibitor of the HIV-1 encoded protease that is essential for the maturation of the infectious virus. The drug exhibited dose-dependent kinetics in all species studied (rat, dog and monkey); the apparent clearance decreased when the dose was increased. However, the dose-dependency cannot be explained by Michaelis-Menten kinetics. L-754,394 in plasma declined log-linearly with time, but with an apparent half-life that increased with dose. The apparent terminal half-life of L-754,394 in rats increased from 20 min at 0.5 mg/kg i.v. to 118 min at 10 mg/kg i.v. Furthermore, L-754,394 exhibited time-dependent pharmacokinetics. After chronic i.v. doses for 7 days (1 mg/kg/dose/day), the apparent clearance of L-754,394 in rats decreased from 87 ml/min/kg after the first dose to 25 ml/min/kg after the last dose. Similar results were observed in dogs and monkeys. In vitro spectral studies indicated that approximately 40 to 60% of the content of cytochrome P-450 was inactivated when L-754,394 (10 microM) was incubated with rat, dog and monkey liver microsomes in the presence of NADPH. Little or no inactivation of cytochrome P-450 was observed when either NADPH or L-754,394 was omitted. In addition, L-754,394 selectively inhibited CYP 2C11-dependent testosterone 2 alpha- and 16 alpha-hydroxylase activity and CYP 3A1/2-dependent testosterone 6 beta-hydroxylase activity, but not CYP 2D1/2-dependent bufuralol 1'-hydroxylase activity nor CYP 1A2-dependent phenacetin O-deethylase activity in rat liver microsomes.(ABSTRACT TRUNCATED AT 250 WORDS)
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
January 1994,
Drug metabolism and disposition: the biological fate of chemicals,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
July 1995,
Drug metabolism and disposition: the biological fate of chemicals,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
September 1997,
Toxicology and applied pharmacology,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
October 1992,
The Journal of pharmacology and experimental therapeutics,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
August 1988,
Journal of pharmaceutical sciences,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
March 1994,
Pharmaceutical research,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
December 2010,
Xenobiotica; the fate of foreign compounds in biological systems,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
January 1985,
Drug metabolism and disposition: the biological fate of chemicals,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
January 1998,
Chirality,
J H Lin, and
M Chiba, and
I W Chen, and
K J Vastag, and
J A Nishime, and
B D Dorsey, and
S R Michelson, and
S L McDaniel
February 2005,
Current opinion in infectious diseases,
